Altered susceptibility to collagen-induced arthritis in transgenic mice with aberrant expression of interleukin-1 receptor antagonist

Arthritis and Rheumatism

Volumn 41, Issue 10, 1998, Pages 1798-1805

  Ma, Yuhe ^a   Thornton, Sherry ^a   Boivin, Gregory P ^b   Hirsh, David ^c   Hirsch, Raphael ^a   Hirsch, Emmet ^c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI   (United States)

^c College of Physicians and Surgeons ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; AUTOIMMUNE DISEASE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE PREDISPOSITION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HISTOPATHOLOGY; HUMORAL IMMUNITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIBODY FORMATION; ARTHRITIS, EXPERIMENTAL; B-LYMPHOCYTES; COLLAGEN; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, CELLULAR; IMMUNIZATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MICE; MICE, TRANSGENIC; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; SIALOGLYCOPROTEINS; T-LYMPHOCYTES;

EID: 0031695366     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199810)41:10<1798::AID-ART11>3.0.CO;2-L     Document Type: Article

References (33)

1. Nouri AME, Panayi GS, Goodman SM. Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids. Clin Exp Immunol 1984;55:295-302.
2. MacNaul KL, Hutchinson NI, Parsons JN, Bayne EK, Tocci MJ. Analysis of IL-1 and TNFα gene expression in human rheumatoid synoviocytes and normal monocytes by in situ hybridization. J Immunol 1990;145:4154-66.
3. Van de Loo AAJ, van den Berg WB. Effects of murine recombinant interleukin 1 on synovial joints in mice: measurement of patellar cartilage metabolism and joint inflammation. Ann Rheum Dis 1990;49:238-45.
4. Horn JT, Bendele AM, Carlson DG. In vivo administration with IL-1 accelerates the development of collagen-induced arthritis in mice. J Immunol 1988;141:834-41.
5. Staite ND, Richard KA, Aspar DG, Franz KA, Galinet LA, Dunn CJ. Induction of an acute erosive monarticular arthritis in mice by interleukin-1 and methylated bovine serum albumin. Arthritis Rheum 1990;33:253-60.
6. Geiger T, Towbin H, Cosenti-Vargas A, Zingel O, Arnold J, Rordorf C, et al. Neutralization of interleukin-1β activity in vivo with a monoclonal antibody alleviates collagen-induced arthritis in DBA/1 mice and prevents the associated acute-phase response. Clin Exp Rheumatol 1993;11:515-22.
7. Joosten LAB, Helsen MMA, van de Loo FAJ, van den Berg WB. Amelioration of established collagen-induced arthritis (CIA) with anti-IL-1. Agents Actions 1994;41:C174-6.
8. Dinarello CA. Interleukin-1 and interleukin-1 antagonism. Blood 1991;77:1627-52.
9. Hirsch E, Irikura VM, Paul SM, Hirsh D. Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice. Proc Natl Acad Sci U S A 1996;93:11008-13.
10. Wooley PH, Whalen JD, Chapman DL, Berger AE, Richard KA, Aspar DG, et al. The effect of an interleukin-1 receptor antagonist protein on type II collagen-induced arthritis and antigen-induced arthritis in mice. Arthritis Rheum 1993;36:1305-14.
11. Joosten LAB, Helsen MMA, van de Loo FAJ, van den Berg WB. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFα, anti-IL-1α/β, and IL-1Ra. Arthritis Rheum 1996;39:797-809.
12. Bandara G, Mueller GM, Galea-Lauri J, Tindal MH, Georgescu HI, Suchanek MK, et al. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci U S A 1993;90:10764-8.
13. Otani K, Nita I, Macaulay W, Georgescu HI, Robbins PD, Evans CH. Suppression of antigen-induced arthritis in rabbits by ex vivo gene therapy. J Immunol 1996;156:3558-62.
14. Makarov SS, Olsen JC, Johnston WN, Anderle SK, Brown RR, Baldwin AS, et al. Suppression of experimental arthritis by gene transfer of interleukin 1 receptor antagonist cDNA. Proc Natl Acad Sci U S A 1996;93:402-6.
15. Roessler BJ, Hartman JW, Vallance DK, Latta JM, Janich SL, Davidson BL. Inhibition of interleukin-1-induced effects in synoviocytes transduced with the human IL-1 receptor antagonist cDNA using an adenoviral vector. Hum Gene Ther 1995;6:307-16.
16. Bakker AC, Joosten LAB, Arntz OJ, Helsen MMA, Bendele AM, van de Loo FAJ, et al. Prevention of murine collagen-induced arthritis in the knee and ipsilateral paw by local expression of human interleukin-1 receptor antagonist protein in the knee. Arthritis Rheum 1997;40:893-900.
17. Smith MF Jr, Eidlen D, Brewer MT, Eisenberg SP, Arend WP, Gutierrez-Hartmann A. Human IL-1 receptor antagonist promoter: cell type-specific activity and identification of regulatory regions. J Immunol 1992;149:2000-7.
18. Hughes C, Wolos JA, Giannini EH, Hirsch R. Induction of T cell anergy in an experimental model of autoimmunity using nonmitogenic anti-CD3 monoclonal antibody. J Immunol 1994;153: 3319-25.
19. Leo O, Foo M, Sachs DH, Samelson LE, Bluestone JA. Identification of a monoclonal antibody specific for a murine T3 polypeptide. Proc Natl Acad Sci U S A 1987;84:1374-8.
20. Wooley PH, Luthra HS, Stuart JM, David CS. Type II collagen-induced arthritis in mice: major histocompatibility complex (I region) linkage and antibody correlates. J. Exp Med 1981;154:688-700.
21. Myers LK, Terato K, Seyer JM, Stuart JM, Kang AH. Characterization of a tolerogenic T cell epitope of type II collagen and its relevance to collagen-induced arthritis. J Immunol 1992;149:1439-43.
22. Brand DD, Myers LK, Terato K, Whittington KB, Stuart JM, Kang AH, et al. Characterization of the T cell determinants in the induction of autoimmune arthritis by bovine alpha 1 (II)-CB11 in H-2q mice. J Immunol 1994;152:3088-97.
23. Watson WC, Townes AS. Genetic susceptibility to murine collagen II autoimmune arthritis. J Exp Med 1985;162:1878-91.
24. Sawchuk SJ, Boivin GP, Duwel L, Ball W, Trapnell B, Bove K, et al. Anti-T cell receptor monoclonal antibody prolongs transgene expression following adenoviral-mediated in vivo gene transfer to mouse synovium. Hum Gene Ther 1996;7:499-506.
25. Courtenay JS, Dallman MJ, Dayan AD, Martin A, Mosedale B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 1980;283:666-8.
26. Holmdahl R, Klareskog L, Rubin K, Larsson E, Wigzell H. T lymphocytes in collagen II-induced arthritis in mice: characterization of arthritogenic collagen II-specific T-cell lines and clones. Scand J Immunol 1985;22:295-306.
27. Stuart JM, Townes AS, Kang AH. Nature and specificity of the immune response to collagen in type II collagen-induced arthritis in mice. J Clin Invest 1982;69:673-83.
28. Holmdahl R, Rubin K, Klareskog L, Larsson E, Wigzell H. Characterization of the antibody response in mice with type II collagen-induced arthritis, using monoclonal anti-type II collagen antibodies. Arthritis Rheum 1986;29:400-10.
29. Ranges GE, Sriram S, Cooper SM. Prevention of type II collagen-induced arthritis by in vivo treatment with anti-L3T4. J Exp Med 1985;162:1105-10.
30. Granowitz EV, Porat R, Mier JW, Pribble JP, Stiles DM, Bloedow DC, et al. Pharmacokinetics, safety and immunomodulatory effects of human recombinant interleukin-1 receptor antagonist in healthy humans. Cytokine 1992;4:353-60.
31. Firestein GS, Boyle DL, Yu C, Paine MM, Whisenand TD, Zvaifler NJ, et al. Synovial interleukin-1 receptor antagonist and interleukin-1 balance in rheumatoid arthritis. Arthritis Rheum 1994;37:644-52.
32. Campion GV, Lebsack ME, Lookabaugh J, Gordon G, Catalano M, and the IL-1Ra Arthritis Study Group. Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1092-101.
33. Nuki G, Rozman B, Pavelka K, Emery P, Lookabaugh J, Musikic P. Interleukin-1 receptor antagonist continues to demonstrate clinical improvement in rheumatoid arthritis [abstract]. Arthritis Rheum 1997;40 Suppl 9:S224.